XTEN-Annexin A5: XTEN Allows Complete Expression of Long-Circulating Protein-Based Imaging Probes as Recombinant Alternative to PEGylation | Journal of Nuclear Medicine
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers - ScienceDirect
Introduction to XTEN v1
Addgene: pCAG-rAPOBEC1-gs-XTEN-gs-hdenAsCas12a(E174R/S542R/K548R/D908A)-NLS(nucleoplasmin)-gs-UGI-NLS(SV40)(enAsBE1.1) (RTW1352)
Drug Discovery News on Twitter: "#Amunix closes $117M #SeriesB #financing to advance its masked #protease-activated #Tcell engagers (#XPATs) & #cytokines (#XPACs) Look to advance AMX-818 XPAT vs #HER2-expressing solid #tumors to clinic
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers - ScienceDirect
Multivalent Antiviral XTEN–Peptide Conjugates with Long in Vivo Half-Life and Enhanced Solubility
XTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based Cytostatic | PLOS ONE
XTEN Conjugation v1
WO2013130684A1 - Xten-folate conjugate compositions and methods of making same - Google Patents
RCSB PDB - 7KWO: rFVIIIFc-VWF-XTEN (BIVV001)
Targeted Base Editing Systems Are Available for Plants: Trends in Plant Science
XTENylation Service - Profacgen
Addgene: pCAG-NLS(SV40)x2-rAPOBEC1-gs-XTEN-gs-hdLbCas12a(D832A)-gs-UGI-NLS(SV40)(LbBE1.4) (RTW1293) Sequences
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers - ScienceDirect
Team:NUS Singapore-Sci/molecular dynamics - 2018.igem.org
XTEN-Annexin A5: XTEN Allows Complete Expression of Long-Circulating Protein-Based Imaging Probes as Recombinant Alternative to
Frontiers | CRISPR-Assisted Multiplex Base Editing System in Pseudomonas putida KT2440
Terminal plasma half-lives of XTEN protein polymers. | Download Table
Expanding the genome-targeting scope and the site selectivity of high-precision base editors | Nature Communications
Addgene: pCAG-rAPOBEC1-gs-XTEN-gs-hdenAsCas12a(E174R/S542R/K548R/D908A)-NLS(nucleoplasmin)-gs-UGI-NLS(SV40)(enAsBE1.1) (RTW1352) Sequences
T Cell Engagers | XPAT™ Platform | Amunix Pharmaceuticals
Team:NUS Singapore-Sci/Editor Overview - 2018.igem.org
Dually Reactive Long Recombinant Linkers for Bioconjugations as an Alternative to PEG | ACS Omega
WO2017024060A1 - Factor ix fusion proteins and methods of making and using same - Google Patents
